Craig Martin, PharmD, BCPS
Dr. Martin serves as the clinical pharmacist for University of Kentucky Hospital's Antimicrobial Management Team...
Read More
The clinical monograph 5-ASA Treatment for Ulcerative Colitis: What’s on the Horizon? will highlight clinically relevant issues regarding the use of 5-aminosalicylate (5-ASA) therapies in the treatment of UC and Crohn’s disease. With ongoing exploration and advancements in 5-ASA formulations, there is a distinct educational need to educate gastroenterologists on newly released safety and effi cacy data. A thorough understanding of treatment option diff erences will help facilitate...
Read More
The recognition of risk factors is essential for ensuring optimal outcomes after kidney transplantation. The dynamically changing characteristics of recipients and donors are transforming allocation policy, patient care, and outcomes. The development of a new and improved process for identifying and assessing risk is urgently needed. The American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST) 2008 Winter Symposia focused on emerging issues in high...
Read More
Every year, hundreds of thousands of children are subjected to invasive procedures, including venipuncture and intravenous cannulation. Although procedural pain is very common, it continues to be underdiagnosed and undertreated despite the availability of multiple validated modalities for pain assessment and treatment. Accurate pediatric procedural pain evaluation requires knowledge of the existing assessment tools, such as visual analogue and faces pain scales, as well as behavioral and...
Read More
Social and clinical advances in the management of human immunodeficiency virus (HIV) infection and the acquired immune deficiency syndrome (AIDS) continue to occur across the globe. Significant accomplishments include reductions in HIV-associated morbidity and mortality, introduction of less complex medications and dosing regimens, more thorough understandings of the processes surrounding HIV infection, and development of stronger social program infrastructures. As efforts to combat HIV and...
Read More
Post-transplant lymphoproliferative disorders (PTLD) encompass a wide spectrum of mainly B-cell lymphoproliferative disorders with severity ranging from benign polyclonal syndromes to malignant monoclonal lymphoproliferative malignant diseases. At clinical presentation, PTLD may be localized or widely disseminated, and may commonly involve the transplanted allograft.
Epstein-Barr virus (EBV) is the causative agent of the vast majority of PTLD. Patients who are EBV...
Read More
This activity presented by...
Raymund R. Razonable, MD
Consultant, Division of Infectious Diseases
Section of Transplant Infectious Diseases
Mayo...